Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MacuShield
- Development stage
- Unknown
- Lead developer
- Alliance Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
MacuShield is an eye health dietary supplement formulated to support and maintain healthy vision, particularly in individuals at risk of or experiencing age-related macular degeneration (AMD). The core formulation, known as LMZ3, contains a specific 10:10:2 ratio of three macular carotenoids: lutein (10 mg), meso-zeaxanthin (10 mg), and zeaxanthin (2 mg). These carotenoids naturally accumulate in the macula lutea of the eye, where they form the macular pigment. MacuShield works by enhancing macular pigment optical density (MPOD), filtering harmful short-wavelength blue light, and acting as a potent antioxidant to neutralize reactive oxygen species (ROS) and reduce oxidative stress in the retina. Originally developed by MacuVision Europe, the brand was acquired by Alliance Pharma in 2015 and is marketed in various regions, including Pakistan by AGP.
- Brand names
- MacuShieldMacuShield GoldMacuShield OriginalMacuShield Original+
- Other names
- LMZ3LMZ-3LMZ 3lutein + meso-zeaxanthin + zeaxanthinlutein/meso-zeaxanthin/zeaxanthin
Beyond the preview
Go deeper on MacuShield.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MacuShield.